N-((3,4-Dimethoxyphenyl)(8-hydroxyquinolin-7-yl)methyl)benzamide

Catalog No. :
ACKUQA395
CAS No. :
420827-50-5
Molecular Formula :
C25H22N2O4
Molecular Weight :
414.46

IUPAC Name:N-((3,4-dimethoxyphenyl)(8-hydroxyquinolin-7-yl)methyl)benzamide

N-((3,4-Dimethoxyphenyl)(8-hydroxyquinolin-7-yl)methyl)benzamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$504.00Login to see priceIn stockInquiry
250mg98%$856.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-((3,4-Dimethoxyphenyl)(8-hydroxyquinolin-7-yl)methyl)benzamide
IUPAC NameN-((3,4-dimethoxyphenyl)(8-hydroxyquinolin-7-yl)methyl)benzamide
Molecular FormulaC25H22N2O4
Molecular Weight414.46
SMILESO=C(NC(C1=CC=C(OC)C(OC)=C1)C2=CC=C3C=CC=NC3=C2O)C4=CC=CC=C4
InChI KeySODCIWIGEOKFSE-UHFFFAOYSA-N
SynonymBenzamide, N-[(3,4-dimethoxyphenyl)(8-hydroxy-7-quinolinyl)methyl]-;N-((3,4-Dimethoxyphenyl)(8-hydroxyquinolin-7-yl)methyl)benzamide;WAY-312461
CAS No.420827-50-5
PubChem CID3132204

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACKUQA395 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKUQA395 route product structure diagram
    ACKUQA395420827-50-5 In Stock
Inquiry

2. ACKUQA395 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACCSVD432 route compound structure diagram
    ACCSVD432532-31-0 In Stock
  4. Then
  5. ACKUQA395 route product structure diagram
    ACKUQA395420827-50-5 In Stock
Inquiry

Comments (0)